FUB-PB-22 (QUFUBIC) is an indole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.
Pharmacology FUB-PB-22 acts as a full agonist with a binding affinity of 0.386nM at CB1 and 0.478nM at CB2 cannabinoid receptors.
Legal status
FUB-PB-22 is an Anlage II controlled substance in Germany. It was scheduled in Japan in July 2014.
As of October 2015 FUB-PB-22 is a controlled substance in China.
It is also banned in Sweden.
See also
2F-QMPSB 5F-PB-22 AM-2201 BB-22 FUB-JWH-018 AB-FUBINACA ADB-FUBINACA AMB-FUBINACA FDU-PB-22 FUB-144 FUB-APINACA MDMB-FUBICA MDMB-FUBINACA PB-22
References